(Q39676752)

13 September 2017

1 reference

title

On the epidemiology of oral contraceptives and disease (English)

1 reference

13 September 2017

1 reference

R L Prentice

1

1 reference

13 September 2017

D B Thomas

series ordinal

2

1 reference

13 September 2017

publication date

1 January 1987

1 reference

Advances in Cancer Research

13 September 2017

published in

1 reference

13 September 2017

volume

49

1 reference

13 September 2017

page(s)

285-401

1 reference

Oral contraception and myocardial infarction revisited: the effects of new preparations and prescribing patterns

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

A case-control study of the possible association between oral contraceptives and malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Liver Cell Carcinoma in Young Women Possibly Induced by Oral Contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Influence of oral contraceptives on the incidence of premalignant and malignant lesions of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Myocardial infarction in younger women. Associated clinical features and relationship to use of oral contraceptive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Human liver tumors in relation to steroidal usage

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Possible association between benign hepatomas and oral contraceptives.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Effects of Oral Contraceptives on the Gallbladder Bile of Normal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Malignant melanoma and oral contraceptive use among women in California

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptive use and malignant melanoma in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptive use and fibrocystic breast disease among pre- and postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and post-molar trophoblastic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Hepatocellular carcinoma. Polygonal cell type with fibrous stroma—an atypical variant with a favorable prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and Progestins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Risk factors for benign breast disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Long-term use of oral contraceptives and risk of invasive cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Thrombotic thrombocytopenic purpura, cholangiocarcinoma, and oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

"Incessant ovulation" and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptive use and the risk of endometrial cancer. The Centers for Disease Control Cancer and Steroid Hormone Study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Liver Tumors and Contraceptive Steroids: Experience With the First One Hundred Registry Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Cervical dysplasia: association with sexual behavior, smoking, and oral contraceptive use?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral Contraception and Increased Risk of Cerebral Ischemia or Thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and stroke in young women. Associated risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Regression analysis of changes in blood pressure with oral contraceptive use.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinico-pathologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Factors affecting the association of oral contraceptives and ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Occurrence of hepatic impairment in women jaundiced by oral contraceptives and in their mothers and sisters

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Liver-Cell Adenomas Associated with Use of Oral Contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral-contraceptive-associated liver tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral-contraceptive use and bacteriuria in a community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Trends in mortality from carcinoma of the liver and the use of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Cancer of the liver and the use of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Risk factors for epithelial ovarian cancer in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Incidence of thyroid disease associated with oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Amenorrhea following use of combined oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma Study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Reduced Incidence of Endometrial Cancer among Postmenopausal Women Treated with Progestogens*

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Hepatocellular carcinoma in a young woman with prolonged exposure to oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Letter: Oral contraceptives and malignant hepatoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

[Liver cell tumor induction by oral contraceptives]

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

The protective role of progesterone in the prevention of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptive use in patients with thromboembolism following surgery, trauma, or infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Breast cancer in relation to patterns of oral contraceptive use

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Factors associated with oral contraceptive use

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

An epidemiologic study of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

The epidemiology of endometrial cancer in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Hepatocellular carcinoma and oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Estrogen use and cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptive use and fasting triglyceride, plasma cholesterol and HDL cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

A Case-Control Study of Oral Contraceptive Use and Breast Cancer23

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

An epidemiologic study of epithelial carcinoma of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and benign breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptive use: association with frequency of hospitalization and chronic disease risk indicators

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Methodologic standards and contradictory results in case-control research

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and fatal subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Mortality risk associated with the use of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and nonfatal stroke in healthy young women

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and nonfatal myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Decreased Risk of Endometrial Cancer among Oral-Contraceptive Users

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Malignant melanoma and oral contraceptives.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Nine year follow-up of a case of benign liver cell adenoma related to oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and breast disease. An epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

A case-control study of cancer of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Blood pressure and contraceptive use.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Deep vein thrombosis and the oestrogen content in oral contraceptives. An epidemiological analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Histology of the endometrium in long-term use of a sequential oral contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Fatal myocardial infarction and the role of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Dose dependent effects of oral progesterone on the oestrogenised postmenopausal endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and cancers of the breast and of the female genital tract. Interim results from a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Risk factors for gall-bladder disease: a cohort study of young women attending family planning clinics

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

The risk of myocardial infarction in former users of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

The Relationship of Oral Contraception to Depressive Symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and breast cancer. A prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Cholangiocarcinoma and oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Fibrocystic breast disease in oral-contraceptive users. A histopathological evaluation of epithelial atypia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

The development of adenocarcinoma of the endometrium in young women receiving long-term sequential oral contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Increased risk of thrombosis due to oral contraceptives: a further report

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and death from myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Myocardial infarction in young women with special reference to oral contraceptive practice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and myocardial infarction in young women: a further report

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptive use in older women and fatal myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Hepatic changes in young women ingesting contraceptive steroids. Hepatic hemorrhage and primary hepatic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Hepatocellular carcinoma associated with oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Letter: Hepatoblastoma associated with an oral contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral-contraceptive-associated liver tumours: occurrence of malignancy and difficulties in diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

The histology of liver tumors in oral contraceptive users observed during a national survey by the American College of Surgeons Commission on cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptive use and breast cancer in young women in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

The pill at 20: an assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Cancer risk as related to use of oral contraceptives during fertile years

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Characteristics that predict risk of breast cancer before and after the menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Atypical hyperplastic lesions of the female breast. A long-term follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

The incidence of cervical cancer and duration of oral contraceptive use

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Use of oral contraceptives, cigarette smoking, and risk of subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives, smoking, and other factors in relation to risk of venous thromboembolic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Risk of vascular disease in women. Smoking, oral contraceptives, noncontraceptive estrogens, and other factors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptive use and early abortion as risk factors for breast cancer in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Relative risk and odds ratio regression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Serial blood pressure measurements and cardiovascular disease in a Japanese cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Hepatocellular carcinoma in a woman on long-term oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

An epidemiologic study of breast cancer and benign breast neoplasias in relation to the oral contraceptive and estrogen use

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and cardiovascular disease: a critique of the epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Myocardial infarction and estrogen therapy in post-menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptive use in relation to nonfatal myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Breast cancer and oral contraceptive use

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Risk factors for uterine fibroids: reduced risk associated with oral contraceptives.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Breast cancer and oral contraceptives: findings in Royal College of General Practitioners' study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives, antithrombin- III activity, and postoperative deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and thromboembolism: a further report

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Thromboembolism and oral contraceptives: an epidemiologic case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Exogenous hormones, reproductive history, and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Endometrial hyperplasia in women on cyclic or continuous estrogen regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral-contraceptive use in relation to myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Risk of Myocardial Infarction in Relation to Current and Discontinued Use of Oral Contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and cardiovascular disease (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and cardiovascular disease (second of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and breast cancer in young women.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Steroid contraceptive use and cervical dysplasia: increased risk of progression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Thrombosis with low-estrogen oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Relationship of oral contraception to development of trophoblastic tumour after evacuation of a hydatidiform mole

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Bacteriuria and oral contraceptives. Routine health examinations of 12,076 middle-class women

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Reproductive and hormonal factors and breast cancer in a Northern Italian population

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and malignant hepatoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Hepatocarcinoma and oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Primary liver tumors and oral contraceptives. Results of a survey

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Investigation of Relation between Use of Oral Contraceptives and Thromboembolic Disease. A Further Report

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Postoperative Thromboembolism and the Use of Oral Contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and benign liver tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Mortality among women participating in the Oxford/Family Planning Association contraceptive study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Fertility after stopping different methods of contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Mortality in oral contraceptive users

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptive use and abortion before first term pregnancy in relation to breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and breast cancer: final report of an epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and stroke: findings in a large prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraception and serious psychiatric illness: absence of an association.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and venous thromboembolism: findings in a large prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Incidence of endometrial cancer in relation to the use of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Incidence of ovarian cancer in relation to the use of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Invasive cervical cancer and combined oral contraceptives. WHO collaborative study of neoplasia and steroid contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and risk of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

Oral contraceptives and pituitary adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

A case control study into the possible effects of birth control pills on pre-clinical carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960801-5

7 January 2021

10.1016/S0065-230X(08)60801-5

Identifiers

DOI

0 references

1 reference